Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Aug 2022 for Nabriva Therapeutics plc, €1,473.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Lisa Dalton: trading record in brief
Lisa Dalton is a declared insider at 2 companies (board member); the most frequent names are Spark Therapeutics, Inc. and Nabriva Therapeutics plc. In total, 7 filings cover trades dated from 18 January 2019 to 31 July 2022.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 3 August 2022 came the latest disclosure, a share grant for €1,473 in Nabriva Therapeutics plc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lisa Dalton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
8,400 shares@ US$0.179100.0% of flowOrdinary SharesSEC:0001104659-22-085788:0
17,500 shares0Ordinary SharesSEC:0001104659-21-098422:0
2 of 2 declarations
